Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update comparing Kollagenase with Iruxol for treatment of cutaneous ulcers has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iruxol (collagenase)
  • Kollagenase

Snippet

Sponsor: Azidus Brasil | Conditions: Ulcers | Phase 2, Phase 3 | Status: SUSPENDED